Close Menu

NEW YORK – LexaGene, which has developed a pathogen detection platform for the veterinary and food safety sectors, is now pivoting to clinical diagnostics by modifying its LX Analyzer platform for viruses, including SARS-CoV-2, the virus behind the COVID-19 pandemic. 

After validating its platform for viral pathogens, the Beverly, Massachusetts-based firm plans to initially launch a multiplex viral diagnostic assay by the third quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.

Nov
10
Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.